OD tablets T20 containing SA-1, from Sawai Pharmaceutical (YJ code: 4229101F1034, standard: 20mg x 1 tablet (equivalent to tegafur)), is a combination chemotherapy drug with tegafur, gimeracil, and oteracil potassium. It is prescribed for various advanced cancers, including gastric, colorectal, pancreatic, and head and neck cancers, aiming to boost antitumor effects and mitigate gastrointestinal toxicities.
OD tablets T20 containing SA-1
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More with the same ingredient
